Durvalumab vs Ondansetron

Durvalumab vs Ondansetron: Overview

This comparison examines the pharmacological differences between Durvalumab and Ondansetron.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Ondansetron: Selective 5-HT3 receptor antagonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Ondansetron — 3-5 hours.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O.

Molecular Weight: Ondansetron — 293.3660 g/mol.

Type: Durvalumab — Antibody; Ondansetron — Small molecule.